It can be followed that the LPS-mediated hyperinflammation model we employed elicits an activation of glia regarding their GFAP-status but this activated glial phenotype does not necessarily correlate to glial alterations concerning S100B secretion observed in IBD. Here, S100B is linked to inflammatory bowel disease.